Xanrox

COTI - starting a huge uptrend (1459% in 2024)

Long
Xanrox Updated   
BYBIT:COTIUSDT.P   COTIUSDT Perpetual Contract
Technical analysis

COTI is starting something huge. The downtrend is over, as you can see on the chart. COTI ended the downtrend with a descending parallel channel. A retest of the channel has already happened, so there is no reason to go down anymore. It is always important to take a look at the volume indicator, and as we can see, the bullish volume is very strong, so the whales are buying and you want to buy with them. 1459% profit is something that is very possible in 2024/2025, but if you do not want to wait a long time, use my profit target 1 and profit target 2.

What Is COTI?

COTI markets itself as the first enterprise-grade fintech platform that empowers organizations to build their own payment solutions as well as digitize any currency to save time as well as money.

COTI is one of the world’s first blockchain protocols that is optimized for decentralized payments and designed for use by merchants, governments, payment DApps and stablecoin issuers.

COTI Pay is the first application. It describes itself as a fully encompassing finance on the blockchain. The COTI Group launched in March of 2017, while the Staking Platform Launched on Jan. 1, 2020.

It is an ecosystem that is designed specifically to meet all of the challenges associated with traditional finance, including latency, fees, global inclusion and risks. This is done through the introduction of the DAG-based protocol as well as infrastructure that is completely scalable, private, inclusive and fast.

The ecosystem has DAG-based blockchain, proof-of-trust consensus algorithm, multiDAG, GTS (Global Trust System), a universal payment solution and a payment gateway.
Comment:
Wave (1) breakout looks real. keep holding.

💡Join VIP Trading Group (signals, my trades):
xanrox.org/vip-trading-group

🟡1-MONTH – 49 USD
🟡3-MONTH – 99 USD
🟡1-YEAR – 199 USD
🟡LIFE-TIME – 299 USD

💡Contact me on Telegram:
t.me/Xanrox
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.